• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.17% Nasdaq Down 0.11%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    7.67 Up 0.10(1.25%) 11:36AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.57
    Open:7.56
    Bid:7.64 x 2800
    Ask:7.65 x 3400
    1y Target Est:8.00
    Beta:0.67
    Earnings Date:Apr 23 - Apr 30 (Est.)
    Day's Range:7.50 - 7.67
    52wk Range:7.16 - 10.26
    Volume:607,079
    Avg Vol (3m):2,654,500
    Market Cap:1.23B
    P/E (ttm):3.89
    EPS (ttm):1.97
    Div & Yield:0.60 (7.90%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIUp 1.25%1.23B
    AMGNUp 0.45%122.11B
    SGENUp 1.98%4.08B
    XOMAUp 3.45%386.61M

    Key Statistics

    Forward P/E (1 yr):3.59
    P/S (ttm):2.61
    Ex-Dividend Date:03-Dec-14

    Analysts

    Annual EPS Est (Dec-14) :2.14
    Quarterly EPS Est (Dec-14) :0.57
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback